Serotonin decreases HIV-1 replication in primary cultures of human macrophages through 5-HT1A receptors

British Journal of Pharmacology

Volumn 154, Issue 1, 2008, Pages 174-182

  Maneglier B ^a,b,c   Guillemin, G J ^d   Clayette, P ^c   Rogez Kreuz, C ^c   Brew, B J ^d   Dormont, D ^c   Advenier, C ^a,b   Therond, P ^b   Spreux Varoquaux, O ^a,b  

^a UPRES EA 220   (France)

^b CENTRE HOSPITALIER DE VERSAILLES   (France)

^c INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

5 HT serotonin; CCR5; HIV; Macrophages

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CHEMOKINE RECEPTOR CCR5 ANTAGONIST; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2 RECEPTOR; VIRUS DNA;

ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS INHIBITION; VIRUS REPLICATION;

EID: 42949150900     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/bjp.2008.80     Document Type: Article

References (57)

1. Abdouh M, Albert PR, Drobetsky E, Filep JG, Kouassi E (2004). 5‐HT 1A ‐mediated promotion of mitogen‐activated T and B cell survival and proliferation is associated with increased translocation of NF‐kappaB to the nucleus. Brain Behav Immun 18: 24–34.
2. Adachi T, Choudhury BK, Stafford S, Sur S, Alam R (2000). The differential role of extracellular signal‐regulated kinases and p38 mitogen‐activated protein kinase in eosinophil functions. J Immunol 165: 2198–2204.
3. Alexander SPH, Mathie A, Peters JA (2007). Guide to Receptors and Channels, 2nd edition (2007 revision). Br J Pharmacol 150 (Suppl 1): S1–S168.
4. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM et al. (1996). CC CKR5: a RANTES, MIP‐1alpha, MIP‐1beta receptor as a fusion cofactor for macrophage‐tropic HIV‐1. Science 272: 1955–1958.
5. Bard JA, Zgombick J, Adham N, Vaysse P, Branchek TA, Weinshank RL (1993). Cloning of a novel human serotonin receptor (5‐HT 7) positively linked to adenylate cyclase. J Biol Chem 268: 23422–23426.
6. Benedict CR, Mathew B, Rex KA, Cartwright Jr J, Sordahl LA (1986). Correlation of plasma serotonin changes with platelet aggregation in an in vivo dog model of spontaneous occlusive coronary thrombus formation. Circ Res 58: 58–67.
7. Capobianchi MR, Abbate I, Antonelli G, Turriziani O, Dolei A, Dianzani F (1998). Inhibition of HIV type 1 BaL replication by MIP‐1alpha, MIP‐1beta, and RANTES in macrophages. AIDS Res Hum Retroviruses 14: 233–240.
8. Chien HF, Yeh KY, Jiang‐Shieh YF, Wei IH, Chang CY, Chang ML et al. (2005). Signal transduction pathways of nitric oxide release in primary microglial culture challenged with gram‐positive bacterial constituent, lipoteichoic acid. Neuroscience 133: 423–436.
9. Choe H (1998). Chemokine receptors in HIV‐1 and SIV infection. Arch Pharm Res 21: 634–639.
10. Cloez‐Tayarani I (2006). Serotonin as a modular of immune function: an overview. Curr Immunology Reviews 2: 27–35.
11. Cloez‐Tayarani I, Changeux JP (2007). Nicotine and serotonin in immune regulation and inflammatory processes: a perspective. J Leukoc Biol 81: 599–606.
12. Cloez‐Tayarani I, Kayyali US, Fanburg BL, Cavaillon JM (2004). 5‐HT activates ERK MAP kinase in cultured‐human peripheral blood mononuclear cells via 5‐HT1A receptors. Life Sci 76: 429–443.
13. Cloez‐Tayarani I, Petit‐Bertron AF, Venters HD, Cavaillon JM (2003). Differential effect of serotonin on cytokine production in lipopolysaccharide‐stimulated human peripheral blood mononuclear cells: involvement of 5‐hydroxytryptamine2A receptors. Int Immunol 15: 233–240.
14. Cocchi F, DeVico AL, Garzino‐Demo A, Arya SK, Gallo RC, Lusso P (1995). Identification of RANTES, MIP‐1 alpha, and MIP‐1 beta as the major HIV‐suppressive factors produced by CD8+ T cells. Science 270: 1811–1815.
15. Cocchi F, DeVico AL, Garzino‐Demo A, Cara A, Gallo RC, Lusso P (1996). The V3 domain of the HIV‐1 gp120 envelope glycoprotein is critical for chemokine‐mediated blockade of infection. Nat Med 2: 1244–1247.
16. Cocchi F, DeVico AL, Yarchoan R, Redfield R, Cleghorn F, Blattner WA et al. (2000). Higher macrophage inflammatory protein (MIP)‐1alpha and MIP‐1beta levels from CD8+ T cells are associated with asymptomatic HIV‐1 infection. Proc Natl Acad Sci USA 97: 13812–13817.
17. Durk T, Panther E, Muller T, Sorichter S, Ferrari D, Pizzirani C et al. (2005). 5‐Hydroxytryptamine modulates cytokine and chemokine production in LPS‐primed human monocytes via stimulation of different 5‐HTR subtypes. Int Immunol 17: 599–606.
18. Dustin ML, Colman DR (2002). Neural and immunological synaptic relations. Science 298: 785–789.
19. Endo Y, Shibazaki M, Nakamura M, Takada H (1997). Contrasting effects of lipopolysaccharides (endotoxins) from oral black‐pigmented bacteria and Enterobacteriaceae on platelets, a major source of serotonin, and on histamine‐forming enzyme in mice. J Infect Dis 175: 1404–1412.
20. Evans DL, Lynch KG, Benton T, Dube B, Gettes DR, Tustin NB et al. (2007). Selective serotonin reuptake inhibitor and substance p antagonist enhancement of natural killer cell innate immunity in human immunodeficiency virus/acquired immunodeficiency syndrome. Biol Psychiatry ; doi: 10.1016/j.biopsych.2007.08.012.
21. Fantuzzi L, Belardelli F, Gessani S (2003). Monocyte/macrophage‐derived CC chemokines and their modulation by HIV‐1 and cytokines: a complex network of interactions influencing viral replication and AIDS pathogenesis. J Leukoc Biol 74: 719–725.
22. Frank MG, Johnson DR, Hendricks SE, Frank JL (2001). Monocyte 5‐HT 1A receptors mediate pindobind suppression of natural killer cell activity: modulation by catalase. Int Immunopharmacol 1: 247–253.
23. Freire‐Garabal M, Nunez MJ, Balboa J, Lopez‐Delgado P, Gallego R, Garcia‐Caballero T et al. (2003). Serotonin upregulates the activity of phagocytosis through 5‐HT 1A receptors. Br J Pharmacol 139: 457–463.
24. Gartner S, Markovits P, Markovitz DM, Kaplan MH, Gallo RC, Popovic M (1986). The role of mononuclear phagocytes in HTLV‐III/LAV infection. Science 233: 215–219.
25. Gordon J, Barnes NM (2003). Lymphocytes transport serotonin and dopamine: agony or ecstasy ? Trends Immunol 24: 438–443.
26. Guillemin GJ, Kerr SJ, Brew BJ (2005a). Involvement of quinolinic acid in AIDS dementia complex. Neurotox Res 7: 103–123.
27. Guillemin GJ, Wang L, Brew BJ (2005b). Quinolinic acid selectively induces apoptosis of human astrocytes: potential role in AIDS dementia complex. J Neuroinflammation 2: 16.
28. Ho WZ, Cherukuri R, Douglas SD (1994). The macrophage and HIV‐1. Immunol Ser 60: 569–587.
29. Idzko M, Panther E, Stratz C, Muller T, Bayer H, Zissel G et al. (2004). The serotoninergic receptors of human dendritic cells: identification and coupling to cytokine release. J Immunol 172: 6011–6019.
30. Jeynes BJ, Issekutz AC, Issekutz TB, Movat HZ (1980). Quantitation of platelets in the microcirculation. Measurement of indium‐111 in microthrombi induced in rabbits by inflammatory lesions and related phenomena. Proc Soc Exp Biol Med 165: 445–452.
31. Kedzierska K, Crowe SM (2002). The role of monocytes and macrophages in the pathogenesis of HIV‐1 infection. Curr Med Chem 9: 1893–1903.
32. Kedzierska K, Crowe SM, Turville S, Cunningham AL (2003). The influence of cytokines, chemokines and their receptors on HIV‐1 replication in monocytes and macrophages. Rev Med Virol 13: 39–56.
33. Kelly MD, Naif HM, Adams SL, Cunningham AL, Lloyd AR (1998). Dichotomous effects of beta‐chemokines on HIV replication in monocytes and monocyte‐derived macrophages. J Immunol 160: 3091–3095.
34. Kim CH, Broxmeyer HE (1999). Chemokines: signal lamps for trafficking of T and B cells for development and effector function. J Leukoc Biol 65: 6–15.
35. Kubera M, Kenis G, Bosmans E, Scharpe S, Maes M (2000). Effects of serotonin and serotonergic agonists and antagonists on the production of interferon‐gamma and interleukin‐10. Neuropsychopharmacology 23: 89–98.
36. Kubera M, Lin AH, Kenis G, Bosmans E, Van Bockstaele D, Maes M (2001). Anti‐inflammatory effects of antidepressants through suppression of the interferon‐gamma/interleukin‐10 production ratio. J Clin Psychopharmacol 21: 199–206.
37. Kubera M, Maes M, Kenis G, Kim YK, Lason W (2005). Effects of serotonin and serotonergic agonists and antagonists on the production of tumor necrosis factor alpha and interleukin‐6. Psychiatry Res 134: 251–258.
38. Laberge S, Cruikshank WW, Beer DJ, Center DM (1996). Secretion of IL‐16 (lymphocyte chemoattractant factor) from serotonin‐ stimulated CD8+ T cells in vitro. J Immunol 156: 310–315.
39. Le Y, Wetzel MA, Shen W, Gong W, Rogers TJ, Henderson EE et al. (2001). Desensitization of chemokine receptor CCR5 in dendritic cells at the early stage of differentiation by activation of formyl peptide receptors. Clin Immunol 99: 365–372.
40. Leon‐Ponte M, Ahern GP, O'Connell PJ (2007). Serotonin provides an accessory signal to enhance T‐cell activation by signaling through the 5‐HT7 receptor. Blood 109: 3139–3146.
41. Merrill JE, Chen IS (1991). HIV‐1, macrophages, glial cells, and cytokines in AIDS nervous system disease. FASEB J 5: 2391–2397.
42. Mizruchin A, Gold I, Krasnov I, Livshitz G, Shahin R, Kook AI (1999). Comparison of the effects of dopaminergic and serotonergic activity in the CNS on the activity of the immune system. J Neuroimmunol 101: 201–204.
43. Mossner R, Lesch KP (1998). Role of serotonin in the immune system and in neuroimmune interactions. Brain Behav Immun 12: 249–271.
44. Naif HM, Li S, Alali M, Sloane A, Wu L, Kelly M et al. (1998). CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection. J Virol 72: 830–836.
45. Napolitano M, Avella M, Goode NT, Botham KM, Bravo E (2004). Cholesterol esterification in human monocyte‐derived macrophages is inhibited by protein kinase C with dual roles for mitogen activated protein kinases. Cell Biol Int 28: 717–725.
46. O'Connell PJ, Wang X, Leon‐Ponte M, Griffiths C, Pingle SC, Ahern GP (2006). A novel form of immune signaling revealed by transmission of the inflammatory mediator serotonin between dendritic cells and T cells. Blood 107: 1010–1017.
47. Pawlowski NA, Kaplan G, Hamill AL, Cohn ZA, Scott WA (1983). Arachidonic acid metabolism by human monocytes. Studies with platelet‐depleted cultures. J Exp Med 158: 393–412.
48. Richter DW, Manzke T, Wilken B, Ponimaskin E (2003). Serotonin receptors: guardians of stable breathing. Trends Mol Med 9: 542–548.
49. Rimaniol AC, Haik S, Martin M, Le Grand R, Boussin FD, Dereuddre‐Bosquet N et al. (2000). Na + ‐dependent high‐affinity glutamate transport in macrophages. J Immunol 164: 5430–5438.
50. Rogez C, Martin M, Dereuddre‐Bosquet N, Martal J, Dormont D, Clayette P (2003). Anti‐human immunodeficiency virus activity of tau interferon in human macrophages: involvement of cellular factors and beta‐chemokines. J Virol 77: 12914–12920.
51. Shen Y, Monsma Jr FJ, Metcalf MA, Jose PA, Hamblin MW, Sibley DR (1993). Molecular cloning and expression of a 5‐hydroxytryptamine7 serotonin receptor subtype. J Biol Chem 268: 18200–18204.
52. Sidibe S, Saal F, Rhodes‐Feuillette A, Lagaye S, Pelicano L, Canivet M et al. (1996). Effects of serotonin and melanin on in vitro HIV‐1 infection. J Biol Regul Homeost Agents 10: 19–24.
53. Smith DG, Guillemin GJ, Pemberton L, Kerr S, Nath A, Smythe GA et al. (2001). Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat. J Neurovirol 7: 56–60.
54. Timmons S, Huzoor A, Grabarek J, Kloczewiak M, Hawiger J (1986). Mechanism of human platelet activation by endotoxic glycolipid‐bearing mutant Re595 of Salmonella minnesota. Blood 68: 1015–1023.
55. Verani A, Gras G, Pancino G (2005). Macrophages and HIV‐1: dangerous liaisons. Mol Immunol 42: 195–212.
56. Wells TN, Power CA, Shaw JP, Proudfoot AE (2006). Chemokine blockers—therapeutics in the making ? Trends Pharmacol Sci 27: 41–47.
57. Wong CK, Cheung PF, Ip WK, Lam CW (2005). Interleukin‐25‐induced chemokines and interleukin‐6 release from eosinophils is mediated by p38 mitogen‐activated protein kinase, c‐Jun N‐terminal kinase, and nuclear factor‐kappaB. Am J Respir Cell Mol Biol 33: 186–194.